Hepatoprotective Screening of Seriphidium kurramense (Qazilb.) Y.R. Ling

Figure 2

Liver histopathological observations of control and treated groups at 40x: (a) control, (b) vehicle control, (c) CCl₄ only, (d) CCl₄+silymarin 200 mg/kg, (e) CCl₄+SKM 150 mg/kg, (f) CCl₄+SMM 300 mg/kg, (g) SKM 150 mg/kg, and (h) SKM 300 mg/kg.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)